![Torben Lund-Hansen](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Torben Lund-Hansen
Technik-/Wissenschafts-/F&E-Leiter bei
YMAS THER
Profil
Torben Lund-Hansen currently works at Y-mAbs Therapeutics, Inc., as Chief Technology Officer & Senior Vice President from 2016.
Dr. Lund-Hansen also formerly worked at Medarex, Inc., as Director-Process Development, Genmab A, as Senior Vice President-Technical Operations, Genmab, Inc., as Senior Vice President-Technical Operations from 2002 to 2009, Novo Nordisk, Inc., as Principal, Genmab MN, Inc., as President & Treasurer from 2008 to 2009, and Lund-Hansen Consulting ApS, as Owner from 2009 to 2016.
Dr. Lund-Hansen received his graduate degree and doctorate degree from the University of Copenhagen.
Aktive Positionen von Torben Lund-Hansen
| Unternehmen | Position | Beginn |
|---|---|---|
| YMAS THER | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2016 |
Ehemalige bekannte Positionen von Torben Lund-Hansen
| Unternehmen | Position | Ende |
|---|---|---|
Lund-Hansen Consulting ApS | Corporate Officer/Principal | 01.01.2016 |
Genmab, Inc.
 Genmab, Inc. Miscellaneous Commercial ServicesCommercial Services Creates and develops human antibodies for the treatment of life-threatening and debilitating diseases | Geschäftsführer | 01.01.2009 |
Genmab MN, Inc. | Präsident | 01.01.2009 |
| GENMAB A/S | Corporate Officer/Principal | - |
Novo Nordisk, Inc.
 Novo Nordisk, Inc. BiotechnologyHealth Technology Develops biological medicines | Corporate Officer/Principal | - |
Ausbildung von Torben Lund-Hansen
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
10
Beziehungen ersten Grades
8
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 8 |
|---|---|
Medarex, Inc.
 Medarex, Inc. BiotechnologyHealth Technology Provides antibody and oncology drug development services | Health Technology |
Genmab A/S
 Genmab A/S BiotechnologyHealth Technology Operates as a biotechnology company for improving the lives of people with cancer and serious diseases through antibody medicines | Health Technology |
University of Copenhagen
 University of Copenhagen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Genmab, Inc.
Genmab, Inc. Miscellaneous Commercial ServicesCommercial Services Creates and develops human antibodies for the treatment of life-threatening and debilitating diseases | Commercial Services |
Novo Nordisk, Inc.
Novo Nordisk, Inc. BiotechnologyHealth Technology Develops biological medicines | Health Technology |
Genmab MN, Inc. | |
Y-mAbs Therapeutics, Inc.
 Y-mAbs Therapeutics, Inc. BiotechnologyHealth Technology Develops radioimmunotherapy and antibody-based oncology therapies for treating cancer | Health Technology |
Lund-Hansen Consulting ApS |
Wählen Sie MarketScreener 
